Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferro

Showing results (21-30 of 420) with videos related to

Pageof 42
Sort By:
Frontiers in Oncology|September 27, 2021
Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?Matteo Ferro, Vincenzo Francesco Caputo, Biagio Barone, et al.
Sensors (Basel, Switzerland)|May 11, 2024
Concept Drift Mitigation in Low-Cost Air Quality Monitoring NetworksGerardo D'Elia, Matteo Ferro, Paolo Sommella, et al.
Diagnosis (Berlin, Germany)|October 21, 2021
Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature reviewDaniela Fasanella, Alessio Antonaci, Francesco Esperto, et al.
Cephalalgia : an International Journal of Headache|January 28, 2026
Clinical and genetic characterization of non-optimal triptan response among migraine patientsEttore Brenna, Matteo Ferro, Marja-Liisa Sumelahti, et al.
NPJ Digital Medicine|January 22, 2026
Large language models improve transferability of electronic health record-based predictions across countries and coding systemsMatthias Kirchler, Matteo Ferro, Veronica Lorenzini, et al.
World Journal of Urology|February 23, 2018
Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patientsMihai Dorin Vartolomei, Shoji Kimura, Matteo Ferro, et al.
Minerva Urology and Nephrology|December 18, 2025
Non-surgical management of kidney stones: between myths and scienceLetizia M Jannello, Alberto Quarà, Alejandra Bravo-Balado, et al.
Current Opinion in Urology|June 24, 2022
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 updateMihai Dorin Vartolomei, Matteo Ferro, Beat Roth, et al.
Expert Review of Anticancer Therapy|August 19, 2022
Factors influencing survival in metastatic castration-resistant prostate cancer therapyMichele Marchioni, Laura Marandino, Daniele Amparore, et al.
International Journal of Molecular Sciences|May 31, 2017
Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Matteo Ferro, Paola Ungaro, Amelia Cimmino, et al.
Pageof 42

Showing results (21-30 of 420) with videos related to

Sort By:
Pageof 42
Frontiers in Oncology|September 27, 2021
Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?Matteo Ferro, Vincenzo Francesco Caputo, Biagio Barone, et al.
Sensors (Basel, Switzerland)|May 11, 2024
Concept Drift Mitigation in Low-Cost Air Quality Monitoring NetworksGerardo D'Elia, Matteo Ferro, Paolo Sommella, et al.
Diagnosis (Berlin, Germany)|October 21, 2021
Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature reviewDaniela Fasanella, Alessio Antonaci, Francesco Esperto, et al.
Cephalalgia : an International Journal of Headache|January 28, 2026
Clinical and genetic characterization of non-optimal triptan response among migraine patientsEttore Brenna, Matteo Ferro, Marja-Liisa Sumelahti, et al.
NPJ Digital Medicine|January 22, 2026
Large language models improve transferability of electronic health record-based predictions across countries and coding systemsMatthias Kirchler, Matteo Ferro, Veronica Lorenzini, et al.
World Journal of Urology|February 23, 2018
Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patientsMihai Dorin Vartolomei, Shoji Kimura, Matteo Ferro, et al.
Minerva Urology and Nephrology|December 18, 2025
Non-surgical management of kidney stones: between myths and scienceLetizia M Jannello, Alberto Quarà, Alejandra Bravo-Balado, et al.
Current Opinion in Urology|June 24, 2022
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 updateMihai Dorin Vartolomei, Matteo Ferro, Beat Roth, et al.
Expert Review of Anticancer Therapy|August 19, 2022
Factors influencing survival in metastatic castration-resistant prostate cancer therapyMichele Marchioni, Laura Marandino, Daniele Amparore, et al.
International Journal of Molecular Sciences|May 31, 2017
Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Matteo Ferro, Paola Ungaro, Amelia Cimmino, et al.
Pageof 42